Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chief operating officer
Research
Charles River's incoming CEO talks R&D processes, reorg goals
Charles River's incoming CEO sees animal-sparing research as “an evolution” of the industry's current R&D methodologies.
Fraiser Kansteiner
Jan 28, 2026 12:58pm
NextStage brings on experienced leader to take COO spotlight
Jul 29, 2025 4:10pm
Zai hires ex-Lilly CFO who left after 'inappropriate' behavior
Mar 15, 2022 12:30pm
Teon poaches Janssen US oncology head—Chutes & Ladders
Mar 11, 2022 9:30am
Merck chief patient officer leaving for NIH—Chutes & Ladders
Mar 4, 2022 9:30am
New Spark, in CEO form, for Roche gene therapy—Chutes & Ladders
Feb 25, 2022 9:30am
